Schweitzer, Noah
Son, Sang Joon
Thurston, Rebecca C.
Li, Jinghang
Chen, Chang-Le
Aizenstein, Howard
Yang, Shaolin
Iordanova, Bistra
Hong, Chang Hyung
Roh, Hyun Woong
Cho, Yong Hyuk
Hong, Sunhwa
Nam, You Jin
Lee, Dong Yun
Park, Bumhee
Kim, Na-Rae
Choi, Jin Wook
Cheong, Jaeyoun
Seo, Sang Woon
An, Young-Sil
Moon, So Young
Han, Seung Jin
Wu, Minjie
Funding for this research was provided by:
National Research Foundation of Korea (NRF-2019R1A5A2026045)
Korea Disease Control and Prevention Agency (6637-303)
National Institute on Aging (R01AG067018)
Article History
Received: 24 May 2024
Accepted: 8 October 2024
First Online: 1 November 2024
Declarations
:
: Written informed consent was obtained from all the participants and caregivers. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Ajou University Hospital Institutional Review Board (Board Approval Number AJIRB-BMR-SUR-16-362, approval date 2016/11/11).
: None.
: Thurston: Astellas, Bayer, Hello Therapeutics (Advisory Board). All other authors declare no competing interests.